Introduction
Executive Summary
Polycystic ovary syndrome: Overview
• Causes
• Mechanism of Action
• Signs and Symptoms
• Diagnosis
• Disease Management
Pipeline Therapeutics
• Comparative Analysis
Therapeutic Assessment
• Assessment by Product Type
• Assessment by Stage and Product Type
• Assessment by Route of Administration
• Assessment by Stage and Route of Administration
• Assessment by Molecule Type
• Assessment by Stage and Molecule Type
Polycystic ovary syndrome - DelveInsight's Analytical Perspective
In-depth Commercial Assessment
• Polycystic ovary syndrome companies' collaborations, Licensing, Acquisition -Deal Value Trends
Polycystic ovary syndrome Collaboration Deals
• Company-Company Collaborations (Licensing / Partnering) Analysis
• Company-University Collaborations (Licensing / Partnering) Analysis
Late Stage Products (Phase III)
• Comparative Analysis
DLBS3233: Dexa Medica
• Product Description
• Research and Development
• Product Development Activities
Drug profiles in the detailed report…..
Mid Stage Products (Phase II)
• Comparative Analysis
Elagolix: Abbvie/ Neurocrine Biosciences
• Product Description
• Research and Development
• Product Development Activities
Drug profiles in the detailed report…..
Early stage products (Phase I)
• Comparative Analysis
Drug Name: Company Name
• Product Description
• Research and Development
• Product Development Activities
Drug profiles in the detailed report…..
Inactive Products
• Comparative Analysis
Polycystic ovary syndrome Key Companies
Polycystic ovary syndrome Key Products
Polycystic ovary syndrome- Unmet Needs
Polycystic ovary syndrome- Market Drivers and Barriers
Polycystic ovary syndrome- Future Perspectives and Conclusion
Polycystic ovary syndrome Analyst Views
Polycystic ovary syndrome Key Companies
Appendix

List of Tables
Table 1 Total Products for Polycystic ovary syndrome
Table 2 Late Stage Products
Table 3 Mid Stage Products
Table 4 Early Stage Products
Table 5 Pre-clinical & Discovery Stage Products
Table 6 Assessment by Product Type
Table 7 Assessment by Stage and Product Type
Table 8 Assessment by Route of Administration
Table 9 Assessment by Stage and Route of Administration
Table 10 Assessment by Molecule Type
Table 11 Assessment by Stage and Molecule Type
Table 12 Inactive Products

List of Figures
Figure 1 Total Products for Polycystic ovary syndrome
Figure 2 Late Stage Products
Figure 3 Mid Stage Products
Figure 4 Early Stage Products
Figure 5 Preclinical and Discovery Stage Products
Figure 6 Assessment by Product Type
Figure 7 Assessment by Stage and Product Type
Figure 8 Assessment by Route of Administration
Figure 9 Assessment by Stage and Route of Administration
Figure 10 Assessment by Molecule Type
Figure 11 Assessment by Stage and Molecule Type
Figure 12 Inactive Products

Key Companies
• Dexa Medica
• Astellas
• EffRx
• Spruce Biosciences
• Neurocrine Biosciences
• Fractyl Laboratories